Styrax Life Sciences Private Limited, a active private limited company, was established on 14 March 2014 in Anakapalle, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232AP2014PTC093548. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹16.40 Cr and a paid-up capital of ₹6.57 Cr.
Formerly known as Beatus Laboratories Private Limited. It upholds a compliant status. Employing 202 professional, Its leadership includes Lakshmi Devi Suryadevara (Director), Suryadevara Venkateswara Rao (Director). It holds ₹234.22 Cr open charges and ₹56.92 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 5G, Atchuthapuram, Rambilli Mandal, Anakapalli, Anakapalle, Andhra Pradesh, 531061.
U24232AP2014PTC093548
093548
14 March 2014
₹16.40 Cr
₹6.57 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Styrax Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmi Devi Suryadevara | Director | 14 Mar 2014 | Current |
| Suryadevara Venkateswara Rao | Director | 14 Mar 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Styrax Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.31% increase. The company also saw a substantial improvement in profitability, with a 49.02% increase in profit. The company's net worth Soared by an impressive increase of 28.98%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Styrax Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,342,192,000.00
₹569,200,137.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2024 | Others | ₹20.00 Cr | Open |
| 29 Mar 2024 | Sidbi | ₹1.65 Cr | Open |
| 04 Oct 2023 | Others | ₹36.00 Cr | Open |
| 30 Jun 2023 | Others | ₹6.87 Cr | Open |
| 23 Mar 2023 | Axis Bank Limited | ₹15.00 Cr | Open |
Explore comprehensive loan charge details -
Styrax Life Sciences has a workforce of 202 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Styrax Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 07 Aug 2023 via Charge ID 100768693 with Others was fully satisfied on 22 Jan 2025. was recorded as a recent event.
The activity A charge with Others of Rs. 20.00 Cr registered on 31 May 2024 with Charge ID 100931283 was modified on 02 Jan 2025. was completed.
A charge with Others of Rs. 36.00 Cr registered on 04 Oct 2023 with Charge ID 100803541 was modified on 10 Dec 2024. was recorded as a recent event.
Progress on Styrax Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 108.40 Cr registered on 27 Aug 2020 with Charge ID 100364802 was modified on 09 Jul 2024. was documented.
A charge with Others of Rs. 20.00 Cr registered on 07 Aug 2023 with Charge ID 100768693 was modified on 03 Jul 2024. was recorded as a recent event.
The CIN of Styrax Life Sciences Private Limited is U24232AP2014PTC093548.
Styrax Life Sciences Private Limited is headquartered at Plot No 5G, Atchuthapuram, Rambilli Mandal, Anakapalli, Anakapalle, Andhra Pradesh, 531061.
Styrax Life Sciences Private Limited was incorporated on 14 March 2014.
The current directors of Styrax Life Sciences Private Limited are
The primary industry of Styrax Life Sciences Private Limited is Manufacturing.
Styrax Life Sciences Private Limited is unlisted.
The authorized capital of Styrax Life Sciences Private Limited is ₹16.40 Cr, and the paid-up capital is ₹6.57 Cr.
The compliance status of Styrax Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX